Amneal Pharmaceuticals (AMRX) Intangibles (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Intangibles of $534.9 million for Q1 2026, down 22.39% year-over-year from $689.1 million in Q1 2025, and down 5.08% quarter-over-quarter from $563.5 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Intangibles (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Intangibles history runs 10 years deep, the most recent figure standing at $534.9 million for Q1 2026.
- In Q1 2026, Intangibles fell 22.39% year-over-year to $534.9 million; the TTM figure through Mar 2026 stood at $534.9 million (down 22.39% YoY), while the FY2025 annual figure was $563.5 million, down 23.06% from the prior year.
- Intangibles for Q1 2026 stood at $534.9 million, down from $563.5 million in the prior quarter.
- The five-year high for Intangibles was $1.2 billion in Q1 2022, with the low at $534.9 million in Q1 2026.
- The 5-year median for Intangibles is $859.3 million (2024), against an average of $872.3 million.
- The sharpest annual moves came in 2022 and 2025: Intangibles decreased 4.21% in 2022, then declined 24.64% in 2025.
- Amneal Pharmaceuticals' Intangibles stood at $1.1 billion in 2022, then dropped by 18.76% to $890.4 million in 2023, then retreated by 17.75% to $732.4 million in 2024, then slipped by 23.06% to $563.5 million in 2025, then dropped by 5.08% to $534.9 million in 2026.
- Business Quant data shows AMRX's Intangibles at $534.9 million in Q1 2026, $563.5 million in Q4 2025, and $587.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.12 Bn |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | 587.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 587.83 Mn |
| Mar 31, 2026 | 534.87 Mn |
| Dec 31, 2025 | 563.50 Mn |
| Sep 30, 2025 | 587.94 Mn |
| Jun 30, 2025 | 649.55 Mn |
| Mar 31, 2025 | 689.14 Mn |
| Dec 31, 2024 | 732.38 Mn |
| Sep 30, 2024 | 780.19 Mn |
| Jun 30, 2024 | 819.94 Mn |
| Mar 31, 2024 | 859.27 Mn |
| Dec 31, 2023 | 890.42 Mn |
| Sep 30, 2023 | 982.53 Mn |
| Jun 30, 2023 | 1.02 Bn |
| Mar 31, 2023 | 1.06 Bn |
| Dec 31, 2022 | 1.10 Bn |
| Sep 30, 2022 | 1.16 Bn |
| Jun 30, 2022 | 1.20 Bn |
| Mar 31, 2022 | 1.21 Bn |
| Dec 31, 2021 | 1.17 Bn |
| Sep 30, 2021 | 1.23 Bn |